Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of guselkumab in psoriatic artrithis and disease progression in patients with confirmed diagnosis of enthesitis.
Dattola A, Bernardini N, Anedda J, Atzori L, Bonifati C, Bruni PL, Graceffa D, Giordano D, Molinelli E, Moretta G, Mugheddu C, Offidani A, Pagnanelli G, Pallotta S, Papini M, Persechino S, Richetta AG, Tolino E, Pellacani G, Potenza C. Dattola A, et al. Among authors: pallotta s. Ital J Dermatol Venerol. 2024 Jun 3. doi: 10.23736/S2784-8671.24.07921-0. Online ahead of print. Ital J Dermatol Venerol. 2024. PMID: 38829271 No abstract available.
Long-Term Effectiveness of Brodalumab for the Treatment of Moderate-To-Severe Psoriasis: A Real-Life Multicenter Study of Up to 3 Years in a Real-Life Italian Cohort.
Caldarola G, Galluzzo M, Bernardini N, Botti E, De Luca E, De Simone C, Mariani M, Moretta G, Pallotta S, Campione E, Peris K. Caldarola G, et al. Among authors: pallotta s. Dermatol Pract Concept. 2024 Apr 1;14(2):e2024152. doi: 10.5826/dpc.1402a152. Dermatol Pract Concept. 2024. PMID: 38810071 Free PMC article.
Identification of immunological patterns characterizing immune-related psoriasis reactions in oncological patients in therapy with anti-PD-1 checkpoint inhibitors.
Morelli M, Carbone ML, Scaglione GL, Scarponi C, Di Francesco V, Pallotta S, De Galitiis F, Rahimi S, Madonna S, Failla CM, Albanesi C. Morelli M, et al. Among authors: pallotta s. Front Immunol. 2024 Mar 1;15:1346687. doi: 10.3389/fimmu.2024.1346687. eCollection 2024. Front Immunol. 2024. PMID: 38495872 Free PMC article.
Characterization of a flexible a-Si:H detector for in vivo dosimetry in therapeutic x-ray beams.
Large MJ, Bashiri A, Dookie Y, McNamara J, Antognini L, Aziz S, Calcagnile L, Caricato AP, Catalano R, Chila D, Cirrone GAP, Croci T, Cuttone G, Dunand S, Fabi M, Frontini L, Grimani C, Ionica M, Kanxheri K, Liberali V, Maurizio M, Maruccio G, Mazza G, Menichelli M, Monteduro AG, Morozzi A, Moscatelli F, Pallotta S, Passeri D, Pedio M, Petringa G, Peverini F, Piccolo L, Placidi P, Quarta G, Rizzato S, Sabbatini F, Servoli L, Stabile A, Talamonti C, Thomet JE, Tosti L, Villani M, Wheadon RJ, Wyrsch N, Zema N, Petasecca M. Large MJ, et al. Among authors: pallotta s. Med Phys. 2024 Jun;51(6):4489-4503. doi: 10.1002/mp.17013. Epub 2024 Mar 3. Med Phys. 2024. PMID: 38432192
The impact of COVID-19 pandemic on the number of first diagnosis and follow-up visits of patients affected by pemphigus, bullous pemphigoid, scleroderma, psoriasis and vitiligo: A single-centre experience.
Moro F, Mariotti F, Pira A, Sobrino L, Pallotta S, Panebianco A, Di Zenzo G. Moro F, et al. Among authors: pallotta s. J Eur Acad Dermatol Venereol. 2024 Jun;38(6):e453-e455. doi: 10.1111/jdv.19885. Epub 2024 Feb 24. J Eur Acad Dermatol Venereol. 2024. PMID: 38400642 No abstract available.
155 results